Tools & Documentations

Our publications

Since its creation, Institut Roche has translated its expertise into numerous successful scientific publications

Veith, I., Mencattini, A., Picant, V., Serra, M., Leclerc, M., Comes, M. C., Mami-Chouaib, F., Camonis, J., Descroix, S., Shirvani, H., Mechta-Grigoriou, F., Zalcman, G., Parrini, M. C., & Martinelli, E. (2021).

Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death. PLOS Computational Biology, 17(3), e1008870.

https://doi.org/10.1371/journal.pcbi.1008870

Mutala, L. B., Deleine, C., Karakachoff, M., Dansette, D., Ducoin, K., Oger, R., Rousseau, O., Podevin, J., Duchalais, E., Fourquier, P., Thomas, W., Gourraud, P. A., Bennouna, J., Brochier, C., Gervois, N., Bossard, C., & Jarry, A. (2021).

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer. Cancers, 13(2), 189.

https://doi.org/10.3390/cancers13020189

Annoussamy, M., Seferian, A. M., Daron, A., Péréon, Y., Cances, C., Vuillerot, C., De Waele, L., Laugel, V., Schara, U., Gidaro, T., Lilien, C., Hogrel, J. Y., Carlier, P., Fournier, E., Lowes, L., Gorni, K., Ly-Le Moal, M., Hellbach, N., Seabrook, T., Czech, C., … NatHis-SMA study group (2021).

Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study. Annals of clinical and translational neurology, 8(2), 359–373.

https://doi.org/10.1002/acn3.51281

Sauvaigo, S., Benkhiat, M., Braisaz, F., Girard, J., Libert, S., Mouret, S., de Fraipont, F., Aspord, C., Bouquet, F., & Leccia, M. T. (2020).

DNA repair-based classification of melanoma cell lines reveals an effect of mutations in BRAF and NRAS driver genes on DNA repair capacity. Biorxiv.

https://doi.org/10.1101/2020.04.29.067900

Mercier, F., Kerioui, M., Desmée, S., Guedj, J., Krieter, O., & Bruno, R. (2020).

Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatment. Journal of pharmacokinetics and pharmacodynamics, 47(6), 613–625.

https://doi.org/10.1007/s10928-020-09714-z

Kerioui, M., Mercier, F., Bertrand, J., Tardivon, C., Bruno, R., Guedj, J., & Desmée, S. (2020).

Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapy. Statistics in medicine, 39(30), 4853–4868.

https://doi.org/10.1002/sim.8756

Baltazar, M., Geoffray, M., Chatham, C., Bouvard, M., Martinez Teruel, A., Monnet, D., Scheid, I., Murzi, E., Couffin-Cadiergues, S., Umbricht, D., Murtagh, L., Delorme, R., Ly Le-Moal, M., Leboyer, M., & Amestoy, A. (2020).

“Reading the Mind in the Eyes” in Autistic Adults is Modulated by Valence and Difficulty : An InFoR Study. Autism Research, 14(2), 380-388.

https://doi.org/10.1002/aur.2390

Vial, J., Huchedé, P., Fagault, S., Basset, F., Rossi, M., Geoffray, J., Soldati, H., Bisaccia, J., Elsensohn, M. H., Creveaux, M., Neves, D., Blay, J. Y., Fauvelle, F., Bouquet, F., Streichenberger, N., Corradini, N., Bergeron, C., Maucort-Boulch, D., Castets, P.,. . . Castets, M. (2020).

Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways. Cell Death Discovery, 6(1).

https://doi.org/10.1038/s41420-020-00302-1

Nafia, I., Toulmonde, M., Bortolotto, D., Chaibi, A., Bodet, D., Rey, C., Velasco, V., Larmonier, C. B., Cerf, L., Adam, J., le Loarer, F., Savina, A., Bessede, A., & Italiano, A. (2020).

IDO Targeting in Sarcoma : Biological and Clinical Implications. Frontiers in Immunology, 11.

https://doi.org/10.3389/fimmu.2020.00274
More contents :

Results :36/110